Renal function disturbances such as glycosuria or proteinuria and in some cases may lead to acute renal failure.
Skin: Diaphoresis, erythema multiforme, exfoliative dermatitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, pemphigus, pruritus, urticaria, alopecia.
Gastrointestinal: Ileus, pancreatitis, hepatic failure, hepatitis (either hepatocellular or cholestatic), jaundice, abdominal pain, vomiting, dyspepsia, constipation, anorexia, stomatitis.
Laboratory Test Findings: Increases in blood urea and serum creatinine and elevations of liver enzymes and/or serum bilirubin have been seen. These are usually reversible upon discontinuation of ACETEC. Hyperkalemia and hyponatremia have occurred. Decreases in hemoglobin and hematocrit have been reported, a small number of cases of neutropenia, thrombocytopenia, bone marrow depression and agranulocytosis have been reported.
Hypersensitivity/Angioneurotic Edema: Angioneurotic edema of the face, extremities, lips, tongue, glottis and/or larynx has been reported rarely.
Respiratory: Pulmonary infiltrates, bronchospasm/asthma, dyspnea, rhinorrhea, sore throat and hoarseness.
Nervous System/Psychiatric: Depression, confusion, somnolence, insomnia, nervousness, paresthesia, vertigo.
View ADR Reporting Link